Scientific Advisory Board welcomes new member, Prof Lina Badimon
The International Aspirin Foundation is delighted and honoured to welcome Professor Lina Badimon to its Scientific Advisory Board.
Scientific Advisory Board welcomes new member, Prof Junbo Ge
The International Aspirin Foundation is delighted and honoured to welcome Professor Junbo Ge to its Scientific Advisory Board.
BBC Radio 4, Inside Health with Dr Mark Porter – full episode
Podcast from BBC Radio 4 Inside Health Programme, first broadcast on 4 October 2016. Dr Mark Porter interviews the International Aspirin Foundation Chairman, Prof Peter Rothwell, on the subject of Mini-Strokes.
2016 September, Winners of the 2016 Senior Science Award Announced
Three world-class professors, Nancy Cook, Michael Gaziano and Julie Buring, from Boston were today, 30th September 2016, announced as the winners of the 2016 International Aspirin Foundation Senior Science Award for their work on the two largest ever randomised trials of Aspirin. You can also read the announcement on the Harvard School of Public Health website (this link opens in a new window)
2016 August, The Aspirin Summaries, Issue 1
This report is provides a relatively concise and current overview of activity, which refects the depth of expertise and knowledge of the members of the Scientifc Advisory Board, from both geographical and scientifc areas.
2016 May, 18 – The Lancet – Published Online
Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B and Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
DISCLAIMER (updated November 2016)
- The information, views and opinions expressed on the International Aspirin Foundation website are not endorsed or approved by members of the Scientific Advisory Board unless otherwise stated
- The Information section on the website is compiled using current published information at the time of writing and whilst every effort has been made to avoid errors, professional clinical judgement is required to interpret the information given. The information given is referenced clearly for further analysis as required
- Every effort is made by the International Aspirin Foundation to see that no misleading or inaccurate data, statement or opinion appear on the website, the International Aspirin Foundation cannot be held responsible for any errors or for any consequences arising from the use of the information contained on the website
- The International Aspirin Foundation, its associates and the Scientific Advisory Board accept no liability whatsoever for the consequences of any such inaccurate or misleading data, information, opinion or statement
- Any information involving drug usage, should only be followed in conjunction with the drug manufacturer’s own published literature in their own country
- Medical sciences evolve on a continual basis and therefore independent verification of the website content should be made
- The information, views, opinions and any other material provided on this website should not be relied upon as a substitute to professional medical advice in relation to any medical condition. The International Aspirin Foundation, its associates and The Scientific Advisory Board accept no liability whatsoever for any consequences arising from any reliance placed on such information, views, opinions and other materials in lieu of professional medical advice
- The Aspirin Foundation activities are supported through a sponsorship of Bayer AG, Berlin, Germany. The sponsor does not have any influence over the operations of the International Aspirin Foundation activities.